Below are just a small sampling of scientific studies that demonstrate the benefit of complementary or alternative (CAM) medicine - sometimes described as complementary or integrative medicine (CIM), in cancer care. Integrative medicine (IM) is a discipline that seeks to bring evidence-informed, non-conventional approaches into conventional medical care in a coordinated and safe manner.
Unfortunately, many pediatric cancer patients may not have access to (or awareness of) quality integrative care. This is why Cancer Response Team exists!
In this study the authors report survival data for a consecutive case series of advanced metastatic breast cancer patients who received a comprehensive clinical program combining conventional treatments with nutrition and supplementation, fitness and mind-spirit instruction at the Block Center for Integrative Cancer Treatment. The authors conclude: "Despite a higher proportion of younger and relapsed patients, survival of metastatic breast cancer patients at the Center was approximately double that of comparison populations and possibly even higher compared to trials published during this period. Explanations for the advantage relative to conventional treatment alone may include the nutritional, nutraceutical, exercise and psychosocial interventions, individually or in combination."
A recent study published in the Journal of Cancer, was conducted at the University of Texas MD Anderson Cancer Center's Integrative Medicine Center between September 2009 and December 2013. The authors concluded: "Overall, an initial integrative oncology consultation resulted in clinically meaningful improvements in psychosocial symptoms for patients who returned for follow-up. Greater overall impact across all symptoms was observed for those reporting a moderate to high symptom burden at initial presentation."
A recent study published in the Journal of Medical Oncology examined the impact of CIM intervention on gastro-intestinal (GI)-related concerns in patients with breast/gynecological cancer undergoing chemotherapy. The authors concluded: "The integration of a 12-week CIM intervention in conventional supportive cancer care may reduce nausea and improve appetite in patients with breast/gynecological cancer undergoing chemotherapy. "
Another recent study published in the British Medical Journal Supportive and Palliative Care examined the impact of a patient-tailored complementary/integrative medicine (CIM) program on sleep quality in patients undergoing chemotherapy for breast and gynaecological cancer. The authors concluded: "A patient-tailored CIM programme may improve sleep quality and related concerns among patients with breast and gynaecological cancer undergoing chemotherapy."
In this study, the authors examined the impact of CIM on the need for supportive cancer care-related medications and found that the group receiving CIM support had a decrease in the use of non-opioid analgesics (NOAs).
Disclaimer:Cancer Response Team, Inc. is not providing any medical advice and has no direct affiliation with any alternative treatment organizations/clinics nor treatment practices. All articles, links, media and associated content are offered strictly as an open resource through the freedom of information and are provided as an accommodation, without any representation or warranty as to their reliability or fitness for any particular situation or purpose. All alternative treatment plans, at the sole discretion and election of, the recipient(s) and/or legal guardian(s) along with and in consultation with their selected alternative practitioner(s). CRT does not advocate or prescribe any particular treatment plans and/or guarantee any results as the organization is not involved in the treatment plan nor the process of providing legal or medical advice.